Home/Filings/4/0001628280-25-039729
4//SEC Filing

Lightcap Jeffrey C 4

Accession 0001628280-25-039729

CIK 0001464521other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 9:00 PM ET

Size

30.4 KB

Accession

0001628280-25-039729

Insider Transaction Report

Form 4
Period: 2025-08-07
Transactions
  • Conversion

    Common Stock

    2025-08-11+1,248,9391,248,939 total(indirect: By HealthCor Partners Fund, L.P.)
  • Conversion

    Series C Preferred Stock

    2025-08-11624,4710 total(indirect: By HealthCor Partners Fund II, L.P.)
    Common Stock (624,471 underlying)
  • Conversion

    Series C Preferred Stock

    2025-08-111,248,9390 total(indirect: By HealthCor Partners Fund, L.P.)
    Common Stock (1,248,939 underlying)
  • Conversion

    Series F Preferred Stock

    2025-08-111,337,3370 total(indirect: By LLC)
    Common Stock (1,337,337 underlying)
  • Award

    Stock Option

    2025-08-07+47,42047,420 total
    Exercise: $19.00Exp: 2035-08-07Common Stock (47,420 underlying)
  • Conversion

    Common Stock

    2025-08-11+4,615,5424,615,542 total(indirect: By LLC)
  • Conversion

    Series D Preferred Stock

    2025-08-111,630,2310 total(indirect: By LLC)
    Common Stock (1,630,231 underlying)
  • Conversion

    Common Stock

    2025-08-11+833,075833,075 total(indirect: By HealthCor Partners Fund II, L.P.)
  • Conversion

    Series E Preferred Stock

    2025-08-111,099,3780 total(indirect: By LLC)
    Common Stock (1,099,378 underlying)
  • Conversion

    Series D Preferred Stock

    2025-08-11208,6040 total(indirect: By HealthCor Partners Fund II, L.P.)
    Common Stock (208,604 underlying)
  • Conversion

    Series F-1 Preferred Stock

    2025-08-11452,5280 total(indirect: By LLC)
    Common Stock (452,528 underlying)
  • Conversion

    Convertible Promissory Note

    2025-08-1196,0680 total(indirect: By LLC)
    Exercise: $15.20Common Stock (96,068 underlying)
Footnotes (7)
  • [F1]Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
  • [F2]Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
  • [F3]Mr. Lightcap is a controlling member of each of HCPCIV 1, LLC, HealthCor Partners Fund II, L.P. and HealthCor Partners Fund, L.P. and may be deemed to have voting and dispositive power with respect to the shares. Mr. Lightcap disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F4]Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
  • [F5]Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
  • [F6]Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis.
  • [F7]The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.

Issuer

Heartflow, Inc.

CIK 0001464521

Entity typeother

Related Parties

1
  • filerCIK 0001519465

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 9:00 PM ET
Size
30.4 KB